- ICH GCP
- US Clinical Trials Registry
- Forskere
- Frankrike
- Multippelt myelom
Medisinske spesialister fra Frankrike merket som etterforskere i kliniske studier som studerer Multippelt myelom
Totalt 106 resultater
-
Lotfi BENBOUKER, MDSett i:
- Tours, CHRU de Tours
Prøver:- NCT02066454 (Hovedetterforsker)
Betingelser: -
Ludovic Fouillet, MDSett i:
- Saint-Étienne, CHU de Saint-Etienne
Prøver:- NCT05259553 (Underetterforsker)
Betingelser: -
Lysiane MOLINA, MDSett i:
- Grenoble, CHU Grenoble
Prøver:- NCT02066454 (Underetterforsker)
Betingelser: -
ManierSett i:
- Lille, CHRU Hopital Claude Huriez
Prøver:- NCT05028348 (Hovedetterforsker)
Betingelser: -
Manuel CLIQUENNOIS, MDSett i:
- Lille, Hopital St Vincent - Ghicl
Prøver:- NCT02066454 (Hovedetterforsker)
Betingelser: -
Marc WETTERWALD, MDSett i:
- Dunkerque, Centre hospitalier
Prøver:- NCT02066454 (Hovedetterforsker)
Betingelser: -
Maria Joao Santiago-Ribeiro, MDSett i:
- Tours, CHU de Tours
Prøver:- NCT03832127 (Hovedetterforsker)
Betingelser: -
Marie-Lorraine ChretienSett i:
- Dijon, CHU Dijon - Hopital du Bocage
Prøver:- NCT05879757 (Hovedetterforsker)
Betingelser: -
Mohamad MOHTYSett i:
- Ile-de-france, Paris Cedex 12, Hôpital Saint-Antoine
- Paris, Hôpital Saint Antoine
Prøver:- NCT03215030 (Hovedetterforsker)
- NCT05444712 (Hovedetterforsker)
Betingelser: -
MohtySett i:
- Paris, CHU Hopital Saint Antoine
Prøver:- NCT05028348 (Hovedetterforsker)
Betingelser: -
moreauSett i:
- Nantes, CHRU Hôtel Dieu
Prøver:- NCT05028348 (Hovedetterforsker)
Betingelser: -
MorelSett i:
- Paris, La Pitié
Prøver:- NCT05028348 (Hovedetterforsker)
Betingelser: -
Mourad TIAB, MDSett i:
- La Roche Sur Yon, CHD Vendee
- La Roche sur Yon, Hematology Unit CHD Vendée
Prøver:- NCT01976182 (Hovedetterforsker)
- NCT02066454 (Hovedetterforsker)
Betingelser: -
Nicolas Aide, MDSett i:
- Caen, CHU de Caen
Prøver:- NCT03832127 (Hovedetterforsker)
Betingelser: -
Olivier TOURNILHACSett i:
- Clermont Ferrand, CHU ESTAING Service de thérapie Cellulaire et hématologique Clinique
- Clermont-Ferrand, CHU Clermont Ferrand - Hopital d'Estaing
- Clermont-Ferrand, CHU Estaing
Prøver:- NCT03779113 (Hovedetterforsker)
- NCT02576496 (Hovedetterforsker)
- NCT05444712 (Hovedetterforsker)
-
Omar BenbrahimSett i:
- Orleans, Hopital de la Source - CHR Orleans
Prøver:- NCT05879757 (Hovedetterforsker)
Betingelser: -
Pacôme Fosse, MDSett i:
- Angers, CHU d'Angers
Prøver:- NCT03832127 (Hovedetterforsker)
Betingelser: -
Pascale CONY-MAKHOUL, MDSett i:
- Annecy, CHRA
Prøver:- NCT02066454 (Underetterforsker)
Betingelser: -
PerrotSett i:
- Toulouse, Pôle IUCT Oncopole CHU
Prøver:- NCT05028348 (Hovedetterforsker)
Betingelser: -
Philippe ReySett i:
- Lyon cedex 08, GSK Investigational Site
- Lyon, Centre Leon Berard
Prøver:- NCT04126200 (Hovedetterforsker)
- NCT04052126 (Underetterforsker)
- NCT04671693 (Underetterforsker)
- NCT05947136 (Underetterforsker)
- NCT02066454 (Hovedetterforsker)
Betingelser:- Multippelt myelom;
- Livskvalitet;
- Lymfom, Non-Hodgkin;
- Leukemi, Myeloid, Akutt;
- Utmattelse;
- Trening;
- Eldret;
- Alder, 80 og over;
- Akutt myeloid leukemi;
- Hodgkins sykdom;
- Osteosarkom;
- Non Hodgkin lymfom;
- Seneffekter;
- Ewings sarkom;
- Testikkelkimcelletumor blandet;
- Ikke-metastatisk brystkarsinom;
- Mykvevssarkom, voksen, stadium IIC;
- Komplikasjon;
- Venøs tromboembolisme;
- Myelom
-
Philippe RodonSett i:
- Périgueux cedex, GSK Investigational Site
Prøver:- NCT04484623 (Hovedetterforsker)
Betingelser: -
Pierre BIRON, MDSett i:
- Lyon, Centre Leon Berard
Prøver:- NCT01774409 (Underetterforsker)
- NCT02066454 (Underetterforsker)
Betingelser: -
Pierre Bories, MDSett i:
- Toulouse, Institut Universitaire du Cancer de Toulouse - Oncopole
Prøver:- NCT05651932 (Hovedetterforsker)
Betingelser: -
Pierre FAURISett i:
- Chambéry, Centre Hospitalier Metropole Savoie - Investigational Site Number : 2500006
Prøver:- NCT04458831 (Hovedetterforsker)
Betingelser: -
Pierre Fenaux, MDSett i:
- Paris, Hôpital St Louis
Prøver:- NCT02649790 (Hovedetterforsker)
- NCT02473146 (Hovedetterforsker)
-
Pierre FeugierSett i:
- Nancy, CHu Nancy
- Other, Vandoeuvre-Les-Nancy Cedex 9, Centre Hospitalier Universitaire de Nancy - Hôpital de Brabois
- Vandeouvre-les-Nancy, GSK Investigational Site
- Vandœuvre-lès-Nancy, CHU de Nancy - Hôpital de Brabois Adultes
- Vandœuvre-lès-Nancy, Chu De Nancy Hop D'Adultes De Brabois
Prøver:- NCT04662255 (Hovedetterforsker)
- NCT04965493 (Hovedetterforsker)
- NCT04404283 (Hovedetterforsker)
- NCT04484623 (Hovedetterforsker)
- NCT05246345 (Hovedetterforsker)
-
Pierre Yvese Salaün, MDSett i:
- Brest, CHU de Brest
Prøver:- NCT03832127 (Hovedetterforsker)
Betingelser: -
Rémy GRESSIN, MDSett i:
- Grenoble, CHU Grenoble
Prøver:- NCT02066454 (Underetterforsker)
Betingelser:
Kliniske studier på Multippelt myelom
-
National Cancer Institute (NCI)Aktiv, ikke rekrutterendeMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)FullførtMyelom-multippel | Myelom, plasmacelleForente stater
-
National Cancer Institute (NCI)AvsluttetMyelom, multippel | Myelom-multippelForente stater
-
Tel-Aviv Sourasky Medical CenterFullførtPlasmacellemyelom | Myelom-multippel | Myelom multippel | Myelom, plasmacelleIsrael
-
National Cancer Institute (NCI)Georgetown University; Hackensack Meridian HealthAvsluttetMyelom-multippel | Myelom, plasmacelle | MyelomatoseForente stater
-
University of ChicagoNational Cancer Institute (NCI)Aktiv, ikke rekrutterendeStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater, Canada
-
Sidney Kimmel Cancer Center at Thomas Jefferson...FullførtStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
University of Southern CaliforniaNational Cancer Institute (NCI); Celgene CorporationAvsluttetStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelomForente stater
-
Case Comprehensive Cancer CenterNational Cancer Institute (NCI)TilbaketrukketStage I Myelom | Stadium II multippelt myelom | Stadium III multippelt myelom